David Sacks argues the viral Anthropic resignation that sparked a global AI-safety panic is not what it appears. He claims the 150-million-view ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Monday - Friday, 6:00 - 9:00 AM ET United States Monday - Friday 6a ET Europe Monday - Friday 13:00 CET Asia Monday - Friday 18:00 SIN/HK Australia Monday - Friday 20:00 SYD "Squawk Box" is the ...

There’s nothing like Halloween to get your spirits up. If your heart beats black and orange, then you've probably got your costume picked out and Halloween songs playlist cued up for the party.

On2, Anthropic CEO Dario Amodei published an essay urging AI companies to slow improvements in frontier-model capabilities ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

OpenAI Chief Scientist Jakub Pachocki said on September 6 that no lab has solved alignment and monitoring well enough to keep ...